NCT01258777View on ClinicalTrials.gov

A Study of the Pharmacokinetics of Golimumab in Japanese and Caucasian Male Subjects

PHASE1CompletedINTERVENTIONAL

Enrollment

49

Participants

Timeline

Start Date

October 31, 2010

Study Completion Date

April 30, 2011

Conditions

Healthy Volunteers

Interventions

DRUG

400 mg golimumab or placebo

Single dose of 400 mg subcutaneously

DRUG

200 mg golimumab or placebo

Single dose of 200 mg subcutaneously

Trial Locations (1)

Unknown

Cypress

Sponsors

Lead Sponsor

All Listed Sponsors

lead

Centocor, Inc.

INDUSTRY